Back to search

Evaluation of the efficacy and safety of paliperidone extended-release in the treatment of acute mania: A randomized, double-blind, dose-response study

Data up to Jan 2025

Published2010
Citations65
References32

Total Citations Per Year

Abstract

References (32)

The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia

1987 • 19,723 citations

A New Depression Scale Designed to be Sensitive to Change

1979 • 12,729 citations

A Rating Scale for Mania: Reliability, Validity and Sensitivity

1978 • 8,000 citations

Bipolar Disorder

2011 • 3,572 citations

A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS

1970 • 3,213 citations

Assessment of suicidal intention: The Scale for Suicide Ideation.

1979 • 2,485 citations

Assessment of suicidal intention: The Scale for Suicide Ideation.

1979 • 2,374 citations

Cross-National Epidemiology of Major Depression and Bipolar Disorder

1996 • 2,176 citations

A Rating Scale for Drug-Induced Akathisia

1989 • 2,135 citations

Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP

1997 • 942 citations

Olanzapine versus Placebo and Haloperidol

1996 • 788 citations

Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo

1997 • 756 citations

Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus Haloperidol

1995 • 558 citations

Treatment of schizophrenia with paliperidone extended-release tablets: A 6-week placebo-controlled trial☆

2006 • 282 citations

Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double‐blind, placebo‐controlled study

2004 • 267 citations

Mood stabilisers plus risperidone or placebo in the treatment of acute mania

2003 • 258 citations

Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): Results of a 6-week, randomized, placebo-controlled study

2007 • 240 citations

Efficacy and Safety of Paliperidone Extended-Release Tablets: Results of a 6-Week, Randomized, Placebo-Controlled Study

2007 • 218 citations

Atypical Antipsychotics in the Treatment of Mania

2006 • 199 citations

Risperidone in the treatment of acute mania

2005 • 189 citations

Frequency of Positive Studies Among Fixed and Flexible Dose Antidepressant Clinical Trials: An Analysis of the Food and Drug Administraton Summary Basis of Approval Reports

2002 • 160 citations

A randomized, placebo‐ and active‐controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder

2010 • 107 citations

Research Design Features and Patient Characteristics Associated With the Outcome of Antidepressant Clinical Trials

2004 • 94 citations

Atypical antipsychotics in bipolar disorder: systematic review of randomised trials

2007 • 92 citations

A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania

2007 • 74 citations

Evaluating dose response from flexible dose clinical trials

2008 • 37 citations

Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder

2008 • 33 citations

Treatment of bipolar disorder: the evolving role of atypical antipsychotics.

2007 • 26 citations

P.2.150 Ziprasidone in adjunctive treatment of acute bipolar mania: A randomized, double-blind placebo-controlled trial

2003 • 23 citations

Quetiapine in the treatment of acute mania: Target dose for efficacious treatment

2007 • 19 citations

A Dunnett–Bonferroni‐based parallel gatekeeping procedure for dose–response clinical trials with multiple endpoints

2008 • 16 citations

Typical neuroleptics vs. atypical antipsychotics in the treatment of acute mania in a natural setting

2005 • 6 citations

Cited By (0)

Loading...